Our Mission: Stronger Evidence

ObvioHealth is on a mission to conduct innovative and efficient trials that deliver stronger evidence for better health outcomes. We use technology to develop more precise and accessible measurement tools to capture more robust and accurate data—so life-improving innovations can get to market faster.

“I have been struck again and again by how important measurement is to improving the human condition."

Bill Gates

Our Difference: Tech and Team

Our success comes from the fusion of experienced clinical researchers and pioneering health technology.

ObvioGo® DCT Platform and App

Powerful, flexible technology to capture and unify more accurate multi-source data.

Virtual Site (COACH) Team

Personalized human connection to boost compliance and retention.

DCT Consulting and CRO Services

Expertise to design and conduct studies from start to finish.

Digital Instruments and Endpoint Expertise

The right tools, outcomes, and endpoints to power studies and deliver stronger evidence.

ObvioHealth in Numbers

ObvioHealth has been innovating clinical trials since 2017, when we launched one of the first-ever DCT platforms with a mobile app. Today, we are an industry leader, designing and running DCTs across the globe that generate more robust and accurate data.


Medication Adherence


ePRO Compliance




Faster Recruitment


Consented Participants
Average rates for ObvioHealth completed studies (versus industry benchmarks, where applicable)
Co-creating the future of clinical trials with these industry leaders.

Meet Our Leadership

Ivan Jarry

Chief Executive Officer

Matty Lynch

Chief Operations Officer

Craig Gravina

Chief Technology Officer

James Hendrick

Sr. VP, Global Commercial Operations

Leslie Pascaud

Chief Marketing Officer

John Cassidy

Chief Financial Officer

Nico O’Kuinghttons

SVP, Business Development

Our Strategic Partners

Work for Us

Remote and hybrid positions, unlimited PTO, and company stock grants are just a few benefits of working for ObvioHealth.

Awards and Recognition

Everest PEAK Matrix®

Inc. 5000 (2x)

Reuters Finalist—Most Valuable Clinical Technology

Scrip Shortlist 

CB News Shortlist